As AI con­tin­ues to en­tice Big Phar­ma, a Car­lyle-led drug­mak­er syn­di­cate shells out $430M for cloud com­put­ing play­er

The AI rev­o­lu­tion per­me­at­ing Big Phar­ma took a big fi­nan­cial step for­ward Wednes­day, with VCs and ma­jor drug­mak­ers com­ing to­geth­er to ac­quire a cloud-fo­cused com­pa­ny.

Led by the Car­lyle Group, the in­vestors will put up $430 mil­lion for a ma­jor­i­ty stake in Saa­ma, a com­pa­ny that col­lects pa­tient da­ta to help speed along the drug de­vel­op­ment process. The in­vest­ment arms of Pfiz­er, Mer­ck, Am­gen and McKesson all par­tic­i­pat­ed in the fi­nanc­ing, in ad­di­tion to oth­er promi­nent life sci­ences VCs like North­pond.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER